Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study

Part of paid clinical trials in Morgantown, West Virginia.

Sponsor
ReNeuron Limited
Study ID
NCT05598775
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
35 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Non Interventional long term safety follow up — OTHER
    Non Interventional long term safety follow up

Study Details

The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival

Key Dates

Start date
Nov 1, 2022
Status verified
Oct 2022
Primary completion
Nov 1, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
9 participants (estimated)

Primary Outcome Measure

Long-term safety study is to follow up subjects treated with CTX0E03 DP [ Time Frame: 4 Years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Amy Miller, RPh, PharmDMorgantownWest Virginia26505-

Find similar trials in Morgantown, WV

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
Amy Miller, RPh, PharmD· Morgantown, WV

Related Studies